# Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers

**Authors:** Marine Boulanger, Jean-François Taillandier, Jérôme Henri, Mathias Devreese, Siegrid De Baere, Aude A. Ferran, Alexis Viel

PMC · DOI: 10.1016/j.psj.2024.104200 · Poultry Science · 2024-08-08

## TL;DR

This study models how sulfonamide antibiotics and trimethoprim behave in broiler chickens, showing that the traditional 1:5 dose ratio may not be effective.

## Contribution

New pharmacokinetic data and modeling reveal that the 1:5 TMP/S dose ratio in broilers does not consistently achieve the intended plasma concentration ratio.

## Key findings

- Trimethoprim distributes more widely in tissues than sulfadiazine and sulfamethoxazole.
- Sulfamethoxazole has the longest elimination half-life among the three drugs.
- The 1:5 TMP/S dose ratio rarely achieves the targeted plasma concentration ratio in broilers.

## Abstract

Sulfonamides (S) are old bacteriostatic antibiotics which are widely prescribed in combination with trimethoprim (TMP) for the treatment of various diseases in food-producing animals such as poultry. Nowadays, the 1:5 dose ratio of TMP/S used in broilers is a direct transposition of the ratio determined in Human decades ago for TMP/sulfamethoxazole (SMX), aiming to obtain a supposed synergistic plasma concentration ratio of 1:19. However, major pharmacokinetics (PK) differences exist according to the sulfonamide used in the combination. Here, we generated new PK data in broilers after a cross-over design with IV and the oral administration of 2 major sulfonamides, sulfadiazine (SDZ) and SMX, in combination with TMP, and analyzed the data via a population pharmacokinetic (popPK) modeling approach. Results showed that TMP has a greater plasma to tissue distribution than both sulfonamides with a higher volume of distribution (0.51 L/kg for SDZ, 0.62 L/kg for SMX and 3.14 L/kg for TMP). SMX has the highest elimination half-life (2.83 h) followed by SDZ and TMP (2.01 h and 1.49 h, respectively). The oral bioavailability of the 3 molecules was approximately 100%. Bodyweight could explain some of the inter-individual variability in the volume of distribution of SDZ and SMX and the clearance of SDZ and TMP, as heavier broilers have higher typical values. Monte Carlo simulations of a large virtual broiler population (n = 1,000) showed that the targeted plasma ratio of TMP:S of 1:19 was rarely or never reached at the individual level for both combinations at the marketed doses and greatly varies over time and between individuals, questioning the relevance of the 1:5 dose ratio for current formulations of TMP/S.

## Linked entities

- **Chemicals:** sulfamethoxazole (PubChem CID 5329), trimethoprim (PubChem CID 5578), sulfadiazine (PubChem CID 5215)

## Full-text entities

- **Chemicals:** S (MESH:D013455), sulfadiazine-trimethoprim (MESH:C024873), Sulfonamides (MESH:D013449), SDZ (MESH:D013411), TMP (MESH:D014295), SMX (MESH:D015662)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11399637/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11399637/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC11399637/full.md

---
Source: https://tomesphere.com/paper/PMC11399637